KnoinDX announced that it has entered into a capital increase agreement for $3,140,000 (CNY 20,000,000) in funding led by Wuhan Easy Diagnosis Biomedicine Co.,Ltd. on November 22, 2021. The transaction included participation from Wuhan Easy Diagnosis Biomedicine Co.,Ltd. for a 20% stake in the company and other investors. Post closing of the transaction, the registered capital of the company will increase from CNY 1,256,250 to CNY 1,570,320.